Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

NMR Spectroscopy & CEST Imaging

Revealing Cancer Metabolism In Vivo

Our research group develops non-invasive metabolic and molecular MR techniques using 1H and X nuclei, comprising high-resolution NMR spectroscopy (MRS) and MR spectroscopic imaging (MRSI) at ultra-high fields (B0 ≥ 7T), chemical exchange saturation transfer (CEST) MR imaging, and hyperpolarized carbon-13 (HYP 13C). A particular clinical research focus is the molecular tissue characterization of brain tumors for the stratification of genetic subtypes and the assessment of response to therapies. Another focus is the development of novel imaging techniques for the improved molecular characterization of breast cancers.

© dkfz.de

Research Topics

  • Imaging of physiological parameters, in particular pH values
  • Assessment of tissues' energy metabolism
  • Assessment of changes in tissues' bulk proteome
  • Identification of imaging surrogates for clinical biomarkers using metabolite signals and molecular contrast mechanisms
  • Development of novel molecular imaging techniques
  • Clinical translation of developed imaging methods

 

Moreover, our research group is participating in the following consortia projects:

  • MIRACLE, the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care (HORIZON-EIC funded project)
  • HYPERBOLIC – Visualizing Hallmarks of Cancer through Tailored Hyperpolarized Magnetic Resonance Imaging (DKTK funded project)

to top
powered by webEdition CMS